Donald F Zoz, MD

Executive Director/Clinical Development Lead, Nerandomilast
Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA

Poster(s):

• Baseline quantitative computed tomography scores in patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) in the FIBRONEER-IPF and FIBRONEER-ILD trials